CA Stock MarketDetailed Quotes

Sernova Biotherapeutics Inc (SVA)

Watchlist
  • 0.150
  • +0.005+3.45%
15min DelayMarket Closed Jan 15 16:00 ET
50.50MMarket Cap-3.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sernova Biotherapeutics Inc (SVA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Oct 31, 2025
(Q4)Oct 31, 2025
(Q3)Jul 31, 2025
(Q2)Apr 30, 2025
(Q1)Jan 31, 2025
(FY)Oct 31, 2024
(Q4)Oct 31, 2024
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
42.27%-10.91M
95.64%-171.13K
40.54%-2.07M
46.99%-3.84M
-13.62%-4.83M
37.72%-18.9M
65.43%-3.92M
22.13%-3.48M
19.94%-7.24M
22.34%-4.25M
Net income from continuing operations
51.10%-15.74M
55.77%-2.2M
45.95%-4.07M
62.01%-3.78M
41.55%-5.7M
17.45%-32.19M
57.55%-4.97M
24.11%-7.54M
-6.38%-9.94M
-21.55%-9.74M
Operating gains losses
----
----
----
----
----
----
----
--0
----
----
Depreciation and amortization
-36.59%342.59K
-63.50%62.22K
13.68%185.05K
-53.63%47.66K
-54.28%47.66K
21.26%540.28K
41.65%170.45K
48.56%162.79K
-5.40%102.79K
-2.55%104.25K
Remuneration paid in stock
31.92%2.3M
269.85%678.34K
-27.66%356.16K
-7.71%544.94K
-31.90%723.46K
-55.28%1.75M
-142.04%-399.37K
-54.12%492.33K
-37.13%590.45K
12.86%1.06M
Deferred tax
---70K
----
----
----
----
--0
----
----
----
----
Other non cashItems
448.03%523.74K
259.00%322.14K
-40.30%154.88K
-53.19%62.89K
95.27%-16.18K
77.75%-150.48K
28.81%-202.6K
35.61%259.44K
205.05%134.37K
24.92%-341.69K
Change In working capital
-84.44%1.74M
-32.54%982.42K
-56.78%1.36M
-137.75%-715.78K
-97.57%113.29K
123.84%11.16M
436.03%1.46M
-23.14%3.14M
408.32%1.9M
139.27%4.67M
-Change in receivables
-68.77%175.47K
-46.42%143.42K
-60.42%166.93K
87.69%-59.69K
-121.05%-75.18K
144.60%561.85K
261.94%267.67K
1,262.55%421.75K
-379.26%-484.76K
-32.91%357.18K
-Change in prepaid assets
339.70%24.16K
-97.27%15.07K
910.12%330.35K
104.10%6.97K
2.13%-328.24K
64.10%5.49K
1,388.19%551.82K
-170.33%-40.78K
-337.79%-170.15K
-105.43%-335.39K
-Change in payables and accrued expense
-85.49%1.54M
29.37%823.93K
-68.84%859.06K
-125.99%-663.05K
-88.88%516.71K
122.88%10.59M
308.68%636.87K
-32.11%2.76M
535.77%2.55M
193.71%4.65M
Cash from discontinued investing activities
Operating cash flow
42.27%-10.91M
95.64%-171.13K
40.54%-2.07M
46.99%-3.84M
-13.62%-4.83M
37.72%-18.9M
65.43%-3.92M
22.13%-3.48M
19.94%-7.24M
22.34%-4.25M
Investing cash flow
Cash flow from continuing investing activities
-99.78%24.96K
20.17K
-99.91%4.78K
0
0
-68.03%11.12M
0
-47.58%5.04M
547.80%4M
-91.29%2.08M
Net PPE purchase and sale
--24.96K
--20.17K
----
----
----
--0
--0
--0
----
----
Net investment purchase and sale
--0
--0
--0
--0
--0
-68.26%11.08M
--0
-47.82%5.04M
556.86%4M
-91.47%2.04M
Net other investing changes
----
----
----
----
----
200.00%35.3K
--0
--0
--0
--35.3K
Cash from discontinued investing activities
Investing cash flow
-99.78%24.96K
--20.17K
-99.91%4.78K
--0
--0
-68.03%11.12M
--0
-47.58%5.04M
547.80%4M
-91.29%2.08M
Financing cash flow
Cash flow from continuing financing activities
1.35%5.14M
-93.24%332.34K
482.22%153.44K
2,675.03%4.63M
151.87%22.38K
906.52%5.07M
4,037.51%4.92M
161.52%26.35K
36.26%166.76K
-114.14%-43.14K
Net issuance payments of debt
2,949.54%4.82M
299.14%83.7K
465.07%153.44K
11,110.20%4.63M
1.60%-42.45K
1.57%-169.23K
3.18%-42.03K
1.89%-42.03K
1.89%-42.03K
-0.70%-43.14K
Net common stock issuance
-94.99%248.64K
----
----
----
----
--4.96M
----
----
----
----
Proceeds from stock option exercised by employees
--0
--0
--0
----
----
--15.75K
--0
--0
----
----
Net other financing activities
-75.20%64.83K
--0
--0
--0
--64.83K
-61.29%261.42K
--0
--68.38K
----
----
Cash from discontinued financing activities
Financing cash flow
1.35%5.14M
-93.24%332.34K
482.22%153.44K
2,675.03%4.63M
151.87%22.38K
906.52%5.07M
4,037.51%4.92M
161.52%26.35K
36.26%166.76K
-114.14%-43.14K
Net cash flow
Beginning cash position
-31.07%6.01M
-98.33%83.62K
-41.89%2M
-81.45%1.21M
-31.07%6.01M
130.98%8.72M
-71.77%5.02M
-72.89%3.44M
-71.06%6.51M
130.98%8.72M
Current changes in cash
-112.11%-5.75M
-81.73%181.39K
-221.04%-1.91M
125.72%790.14K
-117.18%-4.8M
-154.79%-2.71M
110.97%993.07K
-68.97%1.58M
68.70%-3.07M
-111.82%-2.21M
End cash Position
-95.59%265K
-95.59%265K
-98.33%83.62K
-41.89%2M
-81.45%1.21M
-31.07%6.01M
-31.07%6.01M
-71.77%5.02M
-72.89%3.44M
-71.06%6.51M
Free cash from
42.27%-10.91M
95.64%-171.13K
40.54%-2.07M
46.99%-3.84M
-13.62%-4.83M
37.92%-18.9M
65.43%-3.92M
22.30%-3.48M
20.10%-7.24M
23.35%-4.25M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Oct 31, 2025(Q4)Oct 31, 2025(Q3)Jul 31, 2025(Q2)Apr 30, 2025(Q1)Jan 31, 2025(FY)Oct 31, 2024(Q4)Oct 31, 2024(Q3)Jul 31, 2024(Q2)Apr 30, 2024(Q1)Jan 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 42.27%-10.91M95.64%-171.13K40.54%-2.07M46.99%-3.84M-13.62%-4.83M37.72%-18.9M65.43%-3.92M22.13%-3.48M19.94%-7.24M22.34%-4.25M
Net income from continuing operations 51.10%-15.74M55.77%-2.2M45.95%-4.07M62.01%-3.78M41.55%-5.7M17.45%-32.19M57.55%-4.97M24.11%-7.54M-6.38%-9.94M-21.55%-9.74M
Operating gains losses ------------------------------0--------
Depreciation and amortization -36.59%342.59K-63.50%62.22K13.68%185.05K-53.63%47.66K-54.28%47.66K21.26%540.28K41.65%170.45K48.56%162.79K-5.40%102.79K-2.55%104.25K
Remuneration paid in stock 31.92%2.3M269.85%678.34K-27.66%356.16K-7.71%544.94K-31.90%723.46K-55.28%1.75M-142.04%-399.37K-54.12%492.33K-37.13%590.45K12.86%1.06M
Deferred tax ---70K------------------0----------------
Other non cashItems 448.03%523.74K259.00%322.14K-40.30%154.88K-53.19%62.89K95.27%-16.18K77.75%-150.48K28.81%-202.6K35.61%259.44K205.05%134.37K24.92%-341.69K
Change In working capital -84.44%1.74M-32.54%982.42K-56.78%1.36M-137.75%-715.78K-97.57%113.29K123.84%11.16M436.03%1.46M-23.14%3.14M408.32%1.9M139.27%4.67M
-Change in receivables -68.77%175.47K-46.42%143.42K-60.42%166.93K87.69%-59.69K-121.05%-75.18K144.60%561.85K261.94%267.67K1,262.55%421.75K-379.26%-484.76K-32.91%357.18K
-Change in prepaid assets 339.70%24.16K-97.27%15.07K910.12%330.35K104.10%6.97K2.13%-328.24K64.10%5.49K1,388.19%551.82K-170.33%-40.78K-337.79%-170.15K-105.43%-335.39K
-Change in payables and accrued expense -85.49%1.54M29.37%823.93K-68.84%859.06K-125.99%-663.05K-88.88%516.71K122.88%10.59M308.68%636.87K-32.11%2.76M535.77%2.55M193.71%4.65M
Cash from discontinued investing activities
Operating cash flow 42.27%-10.91M95.64%-171.13K40.54%-2.07M46.99%-3.84M-13.62%-4.83M37.72%-18.9M65.43%-3.92M22.13%-3.48M19.94%-7.24M22.34%-4.25M
Investing cash flow
Cash flow from continuing investing activities -99.78%24.96K20.17K-99.91%4.78K00-68.03%11.12M0-47.58%5.04M547.80%4M-91.29%2.08M
Net PPE purchase and sale --24.96K--20.17K--------------0--0--0--------
Net investment purchase and sale --0--0--0--0--0-68.26%11.08M--0-47.82%5.04M556.86%4M-91.47%2.04M
Net other investing changes --------------------200.00%35.3K--0--0--0--35.3K
Cash from discontinued investing activities
Investing cash flow -99.78%24.96K--20.17K-99.91%4.78K--0--0-68.03%11.12M--0-47.58%5.04M547.80%4M-91.29%2.08M
Financing cash flow
Cash flow from continuing financing activities 1.35%5.14M-93.24%332.34K482.22%153.44K2,675.03%4.63M151.87%22.38K906.52%5.07M4,037.51%4.92M161.52%26.35K36.26%166.76K-114.14%-43.14K
Net issuance payments of debt 2,949.54%4.82M299.14%83.7K465.07%153.44K11,110.20%4.63M1.60%-42.45K1.57%-169.23K3.18%-42.03K1.89%-42.03K1.89%-42.03K-0.70%-43.14K
Net common stock issuance -94.99%248.64K------------------4.96M----------------
Proceeds from stock option exercised by employees --0--0--0----------15.75K--0--0--------
Net other financing activities -75.20%64.83K--0--0--0--64.83K-61.29%261.42K--0--68.38K--------
Cash from discontinued financing activities
Financing cash flow 1.35%5.14M-93.24%332.34K482.22%153.44K2,675.03%4.63M151.87%22.38K906.52%5.07M4,037.51%4.92M161.52%26.35K36.26%166.76K-114.14%-43.14K
Net cash flow
Beginning cash position -31.07%6.01M-98.33%83.62K-41.89%2M-81.45%1.21M-31.07%6.01M130.98%8.72M-71.77%5.02M-72.89%3.44M-71.06%6.51M130.98%8.72M
Current changes in cash -112.11%-5.75M-81.73%181.39K-221.04%-1.91M125.72%790.14K-117.18%-4.8M-154.79%-2.71M110.97%993.07K-68.97%1.58M68.70%-3.07M-111.82%-2.21M
End cash Position -95.59%265K-95.59%265K-98.33%83.62K-41.89%2M-81.45%1.21M-31.07%6.01M-31.07%6.01M-71.77%5.02M-72.89%3.44M-71.06%6.51M
Free cash from 42.27%-10.91M95.64%-171.13K40.54%-2.07M46.99%-3.84M-13.62%-4.83M37.92%-18.9M65.43%-3.92M22.30%-3.48M20.10%-7.24M23.35%-4.25M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +16.81%
Sample Name
Sample Code
 +15.76%
Sample Name
Sample Code
 +12.83%
4
BIDU-SW
09888
+5.53%
5
JD HEALTH
06618
+4.62%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -